Enantiomer Excess & Absolute Configuration
Determination

Most biologically active compounds including pharmaceuticals have chiral molecular structures with one or more stereogenic centers. The absolute configuration of pharmaceuticals is very important for biological activity. Generally one enantiomer has medicinal activity while the other enantiomer has no activity. In some cases the opposite enantiomer gives rise to adverse and harmful effects. For this reason it is of great significance to obtain enantiopure compounds and to develop chiral auxiliaries for the determination of their absolute configurations and enantiomeric excess.
Recently, Harada and co-workers have developed the MαNP acid method, which is useful for determining the absolute configuration of chiral alcohols and amines by the 1H NMR anisotropy method.1) The MαNP acid moiety shows a strong anisotropy effect in 1H NMR spectra, which enables one to determine the absolute configuration of chiral alcohols and amines. The following is an example of method applied to (+)-2-butanol. (+)-2-Butanol was allowed to react with (R)-(–)-MαNP and (S)-(+)-MαNP acid to yield (R)- and (S)-ester, respectively, whose 1H NMR spectra were measured and all peaks were fully assigned. The Δδ values [Δδ = δ(R) - δ(S)] were determined for each proton, where δ(R) is the proton chemical shift of alcohol moiety of (R)-MαNP acid ester, and δ(S) is that of (S)-MαNP acid ester. The data are shown in Table 1.

According to the sector rule, when the MαNP ester group and methine proton of the secondary alcohol are fixed in the down/front and down/rear sides, respectively, as shown in Figure 1, protons with a positive Δδ value are placed on the right side and those with a negative Δδ value on the left side, leading to the conclusion that (+)-2-butanol has (S) absolute configuration.
Since the α-position of the carboxylic acid is fully substituted, the MαNP acid does not racemize. Futhermore, the naphthalene moiety has a strong anisotropy effect leading to larger Δδ values.

In addition, these diastereomers can be separated by HPLC with almost base-line separation on silica gel (hexane/EtOAc 20:1):α=1.15 and Rs=1.18. The MαNP acid has the ability to recognize the small difference between methyl and ethyl groups. It is well know that chiral discrimination between methyl and ethyl groups is the most difficult. Therefore, the MαNP acid would be a promising tool for enantioresolution.
Chiral DBD and NBD derivatives are also used as chiral derivatizing reagents for HPLC allowing for highly sensitive measurement of optical purity. Furthermore, Fujii and co-workers used 1-fluoro-2,4-dinitro-5-L-leucineamide as a chiral derivatizing reagent for amino acids. They have reported a non-empirical determination of the absolute configuration by HPLC.2)
The circular dichroic (CD) exciton chirality method has also been used for non-empirical assignments of absolute configurations on a wide variety of compounds. However, since exciton coupling requires two or more interacting chromophores in the same molecule, the method cannot be applied in a straightforward manner to molecules which have only a single site for derivatization. Recently, Nakanishi and co-workers reported that they have developed a bis-zinc porphyrin host to determine the absolute configuration of monoalcohols and monoamines.3) A monoalcohol, e.g., (+)-isomenthol, is derivatized with 3-aminopropylglycine to generate a bidentate ligand as a guest, which is capable of forming the 1:1 host/guest complex with the chromophoric bis-zinc porphyrin host. At this time, the conformation of the two porphyrin moieties reflects the conformation of the ligand. The absolute configuration of (+)-isomenthol is determined from the observation of the interaction of excitons between these two porphyrin moieties.
As described above, excellent methods for the non-empirical determination of the absolute configuration and optical purity have been reported and put into use.

for NMR

for HPLC

for X-ray Crystallography

for Exciton Chirality CD Method

for NMR

M1339 M1339 M1103 M1103 B1720 B1720
M1104 M1104 B1721 B1721 C1021 C1021
D2176 D2176 D2459 D2459 A1657 A1657
N0713 N0713 D2460 D2460 D2175 D2175
A1658 A1658 N0714 N0714 N0482 N0482
P0794 P0794 M0831 M0831 I0334 I0334
B1143 B1143 I0336 I0336 T1520 T1520
M1366 M1366 P1219 P1219 M0830 M0830
D1852 D1852 D1853 D1853 B1161 B1161
B1144 B1144 I0398 I0398 T1521 T1521
M1367 M1367 P1220 P1220 M0829 M0829
N0481 N0481 P0793 P0793 M0832 M0832
I0335 I0335 B1343 B1343 C2184 C2184
M0662 M0662 M0661 M0661 S0473 S0473
S0474 S0474
M1339 (+)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetic Anhydride
M1103 (+)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetyl Chloride [for Determination of the optical purity of Alcohols and Amines]
B1720 (+)-Benzylmethylphenylsilylacetic Acid [for e.e. Determination by NMR]
M1104 (-)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetyl Chloride [for Determination of the optical purity of Alcohols and Amines]
B1721 (-)-Benzylmethylphenylsilylacetic Acid [for e.e. Determination by NMR]
C1021 (-)-Camphanic Acid
D2176 (1R,2R)-(+)-1,2-Diphenylethylenediamine
D2459 (1R,2R)-(-)-N,N'-Dimethylcyclohexane-1,2-diamine
A1657 (1R,2R)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid
N0713 (1R,2R)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid
D2460 (1S,2S)-(+)-N,N'-Dimethylcyclohexane-1,2-diamine
D2175 (1S,2S)-(-)-1,2-Diphenylethylenediamine
A1658 (1S,2S)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid
N0714 (1S,2S)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid
N0482 (R)-(+)-1-(1-Naphthyl)ethylamine
P0794 (R)-(+)-1-Phenylethylamine
M0831 (R)-(+)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetic Acid [Optical Resolving]
I0334 (R)-(+)-alpha-Methylbenzyl Isocyanate
B1143 (R)-(-)-1,1'-Binaphthyl-2,2'-diyl Hydrogen Phosphate
I0336 (R)-(-)-1-(1-Naphthyl)ethyl Isocyanate
T1520 (R)-(-)-2,2,2-Trifluoro-1-(9-anthryl)ethanol [e.e. Determination Reagent by NMR]
M1366 (R)-(-)-2-Methoxy-2-(1-naphthyl)propionic Acid
P1219 (R)-(-)-2-Phenylpropionic Acid
M0830 (R)-(-)-alpha-Methoxyphenylacetic Acid
D1852 (R)-(-)-N-(3,5-Dinitrobenzoyl)-alpha-phenylethylamine
D1853 (R)-(-)-N-(3,5-Dinitrobenzoyl)-alpha-phenylglycine
B1161 (R,R)-(-)-2,3-Butanediol
B1144 (S)-(+)-1,1'-Binaphthyl-2,2'-diyl Hydrogen Phosphate
I0398 (S)-(+)-1-(1-Naphthyl)ethyl Isocyanate
T1521 (S)-(+)-2,2,2-Trifluoro-1-(9-anthryl)ethanol [e.e. Determination Reagent by NMR]
M1367 (S)-(+)-2-Methoxy-2-(1-naphthyl)propionic Acid
P1220 (S)-(+)-2-Phenylpropionic Acid
M0829 (S)-(+)-alpha-Methoxyphenylacetic Acid
N0481 (S)-(-)-1-(1-Naphthyl)ethylamine
P0793 (S)-(-)-1-Phenylethylamine
M0832 (S)-(-)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetic Acid [Optical Resolving]
I0335 (S)-(-)-alpha-Methylbenzyl Isocyanate
B1343 (S,S)-(+)-2,3-Butanediol
C2184 Chirabite-AR
M0662 D-(-)-Mandelic Acid
M0661 L-(+)-Mandelic Acid
S0473 Sodium [(R)-1,2-Diaminopropane-N,N,N',N'-tetraacetato]samarate(III) Hydrate
S0474 Sodium [(S)-1,2-Diaminopropane-N,N,N',N'-tetraacetato]samarate(III) Hydrate

for HPLC

A1657 A1657 N0713 N0713 A1658 A1658
N0714 N0714 I0334 I0334 A5565 A5565
A5566 A5566 I0336 I0336 M1366 M1366
A5561 A5561 A5568 A5568 A5563 A5563
A5577 A5577 I0398 I0398 M1367 M1367
A5560 A5560 A5569 A5569 A5562 A5562
A5578 A5578 I0335 I0335 A5564 A5564
A5567 A5567 A5524 A5524 D2259 D2259
A5523 A5523
A1657 (1R,2R)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid
N0713 (1R,2R)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid
A1658 (1S,2S)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid
N0714 (1S,2S)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid
I0334 (R)-(+)-alpha-Methylbenzyl Isocyanate
A5565 (R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
A5566 (R)-(+)-NBD-Pro-COCl [=(R)-(+)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
I0336 (R)-(-)-1-(1-Naphthyl)ethyl Isocyanate
M1366 (R)-(-)-2-Methoxy-2-(1-naphthyl)propionic Acid
A5561 (R)-(-)-DBD-APy [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
A5568 (R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling]
A5563 (R)-(-)-NBD-APy [=(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
A5577 (R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
I0398 (S)-(+)-1-(1-Naphthyl)ethyl Isocyanate
M1367 (S)-(+)-2-Methoxy-2-(1-naphthyl)propionic Acid
A5560 (S)-(+)-DBD-APy [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
A5569 (S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling]
A5562 (S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
A5578 (S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
I0335 (S)-(-)-alpha-Methylbenzyl Isocyanate
A5564 (S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
A5567 (S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]
A5524 Nalpha-(5-Fluoro-2,4-dinitrophenyl)-D-leucinamide [HPLC Labeling Reagent for e.e. Determination]
D2259 Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-alaninamide [HPLC Labeling Reagent for e.e. Determination]
A5523 Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-leucinamide [HPLC Labeling Reagent for e.e. Determination]

for X-ray Crystallography

C1767 C1767 C1683 C1683 C1766 C1766
C1682 C1682
C1767 N-(2-Carboxy-4,5-dichlorobenzoyl)-(+)-10,2-camphorsultam
C1683 N-(2-Carboxy-4,5-dichlorobenzoyl)-(-)-10,2-camphorsultam
C1766 N-(2-Carboxybenzoyl)-(+)-10,2-camphorsultam
C1682 N-(2-Carboxybenzoyl)-(-)-10,2-camphorsultam

for Exciton Chirality CD Method

for Hydroxyl Groups

A1150 A1150 N0025 N0025 N0048 N0048
B0553 B0553 B0558 B0558 C0134 C0134
C0141 C0141 C0445 C0445 C1182 C1182
D0724 D0724 M0721 M0721 M0576 M0576
N0156 N0156 N0176 N0176 P0961 P0961
P1079 P1079 M1338 M1338 A0690 A0690
B0062 B0062 B0105 B0105 A0482 A0482
A1150 2-Anthracenecarboxylic Acid
N0025 2-Naphthoic Acid
N0048 2-Naphthoyl Chloride
B0553 4-Bromobenzoic Acid
B0558 4-Bromobenzoyl Chloride
C0134 4-Chlorobenzoic Acid
C0141 4-Chlorobenzoyl Chloride
C0445 4-Cyanobenzoic Acid
C1182 4-Cyanobenzoyl Chloride
D0724 4-Dimethylaminobenzoic Acid
M0721 4-Methoxybenzoyl Chloride
M0576 4-Methoxycinnamic Acid
N0156 4-Nitrobenzoic Acid
N0176 4-Nitrobenzoyl Chloride
P0961 4-Phenylbenzoic Acid
P1079 4-Phenylbenzoyl Chloride
M1338 5-(4-Methoxycarbonylphenyl)-10,15,20-triphenyl-21H,23H-porphine
A0690 9-Anthracenecarboxylic Acid
B0062 Benzoic Acid Zone Refined (number of passes:20)
B0105 Benzoyl Chloride
A0482 p-Anisic Acid

for Primary Amino Groups

N0530 N0530 D0645 D0645 D1495 D1495
D0648 D0648
N0530 2,3-Naphthalenedicarboxylic Anhydride
D0645 4-Dimethylaminobenzaldehyde
D1495 4-Dimethylaminobenzaldehyde
D0648 4-Dimethylaminocinnamaldehyde

for Monoalcohols, Monoamines

B2124 B2124 A1371 A1371 B1185 B1185
P1364 P1364
B2124 4-[(tert-Butoxycarbonylamino)methyl]pyridine-2-carboxylic Acid [Reagent for application of the exciton chirality method]
A1371 N-(tert-Butoxycarbonyl)-1,2-diaminoethane
B1185 N-(tert-Butoxycarbonyl)glycine
P1364 Pentamethylene Bis[4-(10,15,20-triphenylporphin-5-yl)benzoate]dizinc(II) [Reagent for application of the exciton chirality method]

Literature

1) N. Harada, M. Watanabe, S. Kuwahara, A. Sugino, Y. Kasai, A. Ichikawa, Tetrahedron : Asymmetry, 2000, 11, 1249; Tokyo Kasei Kogyo Co., Ltd. JP Patent Appl. 2000-115896.
2) K. Fujii, Y. Ikai, H. Oka, M. Suzuki, K. Harada, Anal. Chem., 1997, 69, 5146; K. Fujii, Y. Ikai, T. Mayumi, H. Oka, M. Suzuki, Anal. Chem., 1997, 69, 3346.
3) T. Kurtan, N. Nesnas, F. E. Koehn, Y.-Q. Li, K. Nakanishi, N. Berova, J. Am. Chem. Soc., 2001, 123, 5975.


kdjoad0000003wve